ADPKD Guide
Readable, evidence-first ADPKD treatment, symptoms, diet, trials, and research updates for patients, families, and clinicians.
Methodology References Support GitHub
Patient Guide Treatment Trials Cure
More
Newly Diagnosed Tolvaptan Diet Symptoms Clinicians Methodology References Support
ADPKD Patient Guide Patient reading mode

ADPKD treatment, diet, symptoms, and lifestyle guide

What helps now, what is promising, and what is still weak evidence.

Last reviewed: April 25, 2026

Proven, promising, and not proven

Proven / best-supported

  • Tolvaptan in appropriate high-risk adults (Tier 1)
  • Risk-stratified intervention timing (imaging + eGFR trajectory) (Tier 1)
  • Tight blood pressure management (Tier 1 supportive care)

Promising

  • SGLT2 inhibitors in ADPKD (Tier 2 to Tier 3 signal)
  • SGLT2 inhibitors in ADPKD (Tier 2 to Tier 3 signal)
  • Metabolic and ketogenic strategies (Tier 2 feasibility / Tier 3 efficacy)

Not proven

  • Any claimed human cure
  • High water intake as a standalone disease-modifying prescription
  • Early gene-editing headlines as current therapy

Recent movement

No new evidence cleared review threshold in this cycle.